Breaking the Monoamine Barrier - Glutamatergic Antidepressants in Practice: When and How to Use Them (Module 3)

Breaking the Monoamine Barrier - Personalizing Treatment: Strategies for Incorporating Glutamatergic Therapy (Module 4)

Understanding and Utilizing Digital Therapeutics in MDD: Strategies for Successful Integration (Proceedings from Psych Congress)

Exploring the Utility of Precision Serotonin Receptor Modulation to Address Residual Symptoms and Side Effects in MDD (Proceedings from Psych Congress)

Developing an "Efficacy First" Mindset in the Treatment of MDD with Adjunctive Antipsychotics (Proceedings from Psych Congress)

Atypical Antipsychotics for Depressive Episodes: Clinical Considerations and Strategies in BD vs MDD (Proceedings from Psych Congress)

Pushing Progression Back: Using LAIs to Create Recovery-Focused Treatment Plans in Schizophrenia (Proceedings from Psych Congress)

Kappa Opioid Receptor Antagonism for Anhedonia in MDD: Progress in Precision Psychiatry (Proceedings from Psych Congress)

Navigating the Spectrum of Bipolar Disorder: New Options with Novel Mechanisms of Action (Proceedings from Psych Congress)

Sleep is the Foundation of Mental Health: How to Assess the Bidirectional Relationship of Sleep and Psychiatric Conditions (Proceedings from Psych Congress)

Breaking the Monoamine Barrier: Defying Limitations with Glutamatergic Treatments for MDD (Proceedings from Psych Congress)

Breaking the Monoamine Barrier - The Limits of Monoamines: Why Conventional Antidepressants Fall Short (Module 1)